Explore Stanford technologies available for licensing:

Stanford scientists in Dr.

Stanford inventors have developed technologies for improved islet transplantation using a bioscaffold platform that maintains islet health during and after their transplantation.

Stanford inventors have developed technologies for improved islet transplantation using a bioscaffold platform that maintains islet health during and after their transplantation.

Wastewater treatment facilities commonly add chlorine or chloramines at the end of treatment as a final disinfectant. While effective, any wastewater must be dechlorinated before release to prevent killing aquatic organisms.

Researchers at Stanford have developed a rapid and efficient method for high-throughput genome editing using CRISPR/Cas9. The CRISPR/Cas9 system allows researchers to edit any site in an organism's genome.

Researchers at Stanford have developed methods for the continuous real-time monitoring of biomolecules in live subjects.

Researchers at Stanford have developed a protein, PopTag, that drives phase separation when it is part of a chimeric fusion protein.

Mice that are homozygous for the targeted mutation have a complete cleft of the secondary palate and die within 12 hours of birth. Heterozygotes are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities.

MECA-99 is a previously unpublished EC-specific rat monoclonal antibody (mAb), which in most settings selectively stains capillary EC in adult mice.

Stanford researchers in the Kanan Lab have patented a low-cost, portable, and easy-to-use device designed to rapidly detect elevated ammonia levels from a drop of blood.

Stanford researchers at The Lee Lab have discovered a novel epidermal tumor suppressor to treat squamous cell carcinoma (SCC) by utilizing existing drug therapies.

Stanford inventors have developed a rapid fluorogenic assay for screening of lactam resistant bacterial pathogens. ?-lactam antibiotics are considered to be the most successful class of antibiotics for treating bacterial infections.

Researchers at Stanford have developed non-opiate methods for treating chronic pain and for retrograde transduction of neurons.

Researchers at Stanford have developed a magnetophoretic separation device (MSD) for isolating basophils and other rare cell types from a blood sample. The device applies exponentially increasing magnetic field strength to flowing magnetically tagged cells.

Stanford researchers have designed hydrogels that can be delivered to surgical sites in a patient's body for controlled and sustained release of bacteriophages to treat or prevent bacterial infections.